The present invention provides glucopyranosyloxypyrazole derivatives represented by the general formula: ##STR00001## wherein R.sup.1, R.sup.2 and R.sup.3 represent a hydrogen atom or a halogen atom; R.sup.4 represents a lower alkyl group or a halo(lower alkyl) group; and R.sup.5 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, etc., a pharmaceutically acceptable salt thereof or a prodrug thereof., which exert an excellent inhibitory activity in human SGLT2, and therefore are useful as drugs for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, pharmaceutically acceptable salts thereof or prodrugs thereof, production intermediates thereof and pharmaceutical uses thereof.